Preferred Label : Leukodystrophy, hypomyelinating, 3;
Symbol : HLD3;
CISMeF acronym : HLD3;
Type : Phenotype, molecular basis known;
Description : Autosomal recessive hypomyelinating leukodystrophy-3 (HLD3) is a severe neurologic
disorder characterized by early infantile onset of global developmental delay, lack
of development, lack of speech acquisition, and peripheral spasticity associated with
decreased myelination in the central nervous system (summary by Feinstein et al.,
2010). The disorder is phenotypically similar to X-linked Pelizaeus-Merzbacher disease
(PMD; 312080), which is caused by mutation in the PLP1 gene (300401). For a general
phenotypic description and a discussion of genetic heterogeneity of HLD, see 312080.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the aminoacyl-tRNA synthetase complex-interacting multifunctional
protein 1 gene (AIMP1, 603605.0001);
Prefixed ID : #260600;
Origin ID : 260600;
UMLS CUI : C1850053;
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)